AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 23- Open
- $431.72
- 52-wk high
- $440.62
- High
- $440.51
- 52-wk low
- $262.49
- Low
- $429.38
- Prev close
- $431.26
Smart money
Earnings
Earnings came in 12.3% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $9.56B | $9.90B | $8.62B | $10.05B |
| Cost of what it sold | $3.08B | $1.79B | $2.74B | $2.81B |
| Gross profit | $6.47B | $8.11B | $5.87B | $7.24B |
| What it spent | ||||
| Research and development | $1.90B | $2.15B | $1.72B | $1.87B |
| Sales and admin | $1.72B | $1.95B | $1.60B | $1.75B |
| Other operating costs | $329.0M | $61.0M | -$113.0M | $116.0M |
| Total operating expenses | $3.95B | $4.16B | $3.21B | $3.73B |
| What was left | ||||
| Operating profit | $2.53B | $3.94B | $2.67B | $3.51B |
| Interest on debt | $685.0M | $653.0M | $657.0M | $673.0M |
| Profit before tax | $3.92B | $1.51B | $2.08B | $2.77B |
| Tax | $705.0M | $181.0M | $265.0M | $393.0M |
| Net profit | $3.22B | $1.33B | $1.82B | $2.38B |
| EBITDA | $5.91B | $3.30B | $3.86B | $3.44B |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
82overbought
20D volatility
31%annualized
52-week range
$262.49$440.62
20D support
News
What the news says
50 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Incyte: Cheaper, Growing Faster, And The Market Keeps Paying Up For Amgen
NeutralAug 20Amgen Named to The Wall Street Journal's Inaugural 2026 Best Companies for the Future List
BullishAug 20Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth
BullishAug 20
